Stryker (NYSE:SYK) CEO Kevin Lobo told an investors conference audience in Las Vegas yesterday that the medical device company is still in the mergers & acquisitions hunt, even after its newsmaking buyouts of China’s Trauson Holdings, Israel’s Orthovita and Surpass Medical.
Trauson Holdings
Stryker execs: Trauson acquistion “key component” to emerging market strategy
Stryker‘s (NYSE:SYK) is making moves to step up its game in emerging markets, widening its reach with the recent acquisition of Trauson Holdings, company officials told investors yesterday.
"The goal of this acquisition is to be able to leverage the product portfolio into other emerging markets," Katherine Owen, Stryker’s vice president of strategy, said in a conference call with investors Wednesday.
Stryker inks $764M deal for China’s Trauson Holdings
Stryker (NYSE:SYK) made a HK$7.50-per-share cash bid for Trauson Holdings (HKG:0325), a Chinese medical device company that makes spinal and trauma care products.